Intravenous device MRSA reduced

September 18, 2008

Email this news item to a friend/colleague

The latest quarterly figures on MRSA bloodstream infections, published by the Health Protection Agency today, show that the number of MRSA infections has fallen by 57% compared to the base level in 2003/4 when the target was set.

Mike Farrar, Chief Executive of NHS North West, said: “We are taking healthcare associated infections very seriously. These figures show great progress and that is a tribute to the hard work of NHS staff coupled with the introduction of new products and technologies. We have also successfully recruited new hospital matrons to ensure standards are met.

One of the technologies being evaluated is a skin disinfecting product for use when inserting intravenous lines. Also, the Royal Liverpool and Broadgreen University Hospitals NHS Trust, has formed a partnership with John Hopkins Hospital in Baltimore, USA. John Hopkins Hospital has eradicated all blood borne infections caused by intravenous lines. The hospital has been working with the Strategic Health Authority and Department of Health, along with representatives from Aintree Hospitals and Liverpool PCT, to learn good practice from John Hopkins.

Click here for the full story.